Generic Version of Pylera an H. Pylori Treatment, Now Available
Each capsule contains 140mg of bismuth subcitrate potassium, 125mg of metronidazole, and 125mg of tetracycline hydrochloride.
Each capsule contains 140mg of bismuth subcitrate potassium, 125mg of metronidazole, and 125mg of tetracycline hydrochloride.
Earlier this month, Global Pharma Healthcare had announced a nationwide recall of its artificial tear lubricant eye drops distributed by EzriCare, LLC and Delsam Pharma.
Researchers evaluated clinical trial data and drug databases to provide updated recommendations on antimicrobial dosing for patients with obesity.
The recalled lots of Artificial Tears Lubricant Eye Drops, 10mg in 1mL, ½ fl oz (15mL) bottles were distributed nationwide by EzriCare, LLC and Delsam Pharma.
The investigational intravenous product is a combination of sulbactam, a β-lactam antibiotic, and durlobactam, a broad-spectrum β-lactamase inhibitor.
The guidance provides steps to address the potential for cross-contamination.
The Menveo 1-vial presentation does not require reconstitution before use and is expected to be broadly available in mid-2023.
Topline results were announced from a phase 3 trial evaluating EVO100 for the prevention of chlamydia and gonorrhea infection in women.
In the CRL, the FDA stated that the application could not be approved in its present form and that an additional clinical trial would be required.
Hospitals, pharmacies, and distributors are being asked to immediately discontinue use or distribution of the recalled product.